Closed Loop Medicine has been granted US patents covering advancements in GLP-1 therapies for obesity and diabetes, and direct oral anticoagulants (DOACs) for cardiovascular health.  The company currently holds over 65 filings across 16 patent families.   In the rapidly-established GLP-1 market, the company’s IP covers dose optimisation according to patient-specific factors such as degree of […]